(Q35989911)

11 August 2017

1 reference

title

Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I. (English)

1 reference

11 August 2017

Mark A Moyad

1

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

22

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

466-471

1 reference

Primary prevention of cardiovascular disease: a call to action

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Early detection of high cholesterol levels in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

The influence of finasteride on the development of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Two decades of progress in preventing vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy: part I--lifestyle changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.10.001

10.1016/J.UROLONC.2004.10.001

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference